drugset / Trial / NCT01080677

Caffeine/Propranolol Intervention for Acute Migraine

NCT01080677

Phase 2 Completed 60 enrolled Stanford University
RandomizedFactorialDouble-blindTreatment

Summary

This is a research study to assess the safety of caffeine/propranolol at different dose levels. We want to find out what effects, good and/or bad, it has on patients and their migraines.

Timeline

Start
2007-01
Primary completion
2009-09
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 400 mg Oral
Subject Caffeine Small molecule 1000 mg Oral
Subject Propranolol Small molecule 40 mg Oral

Indications